IRIS
VIGORITA, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.453
EU - Europa 2.130
AS - Asia 1.190
SA - Sud America 455
AF - Africa 34
OC - Oceania 2
Totale 6.264
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.417
RU - Federazione Russa 709
SG - Singapore 509
BR - Brasile 403
IE - Irlanda 400
SE - Svezia 391
CN - Cina 375
UA - Ucraina 198
DE - Germania 156
HK - Hong Kong 137
FI - Finlandia 77
GB - Regno Unito 64
IT - Italia 62
IN - India 37
VN - Vietnam 34
AR - Argentina 20
FR - Francia 19
CA - Canada 18
PL - Polonia 13
IR - Iran 12
MX - Messico 12
UZ - Uzbekistan 12
BD - Bangladesh 11
ZA - Sudafrica 11
TR - Turchia 9
BE - Belgio 8
ID - Indonesia 7
IQ - Iraq 7
MA - Marocco 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
VE - Venezuela 6
ES - Italia 5
GR - Grecia 5
JO - Giordania 5
PY - Paraguay 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CO - Colombia 4
JP - Giappone 4
KE - Kenya 4
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
PK - Pakistan 3
PT - Portogallo 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
LT - Lituania 2
NG - Nigeria 2
NL - Olanda 2
PH - Filippine 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
HR - Croazia 1
JM - Giamaica 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MY - Malesia 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 6.264
Salva come PNG Salva come JPEG
Città #
Dublin 399
Moscow 357
Jacksonville 352
Dallas 331
Chandler 275
Nyköping 265
Singapore 244
Ashburn 238
Dearborn 188
Beijing 160
Hong Kong 137
Cambridge 61
Medford 61
Princeton 61
Los Angeles 55
Ann Arbor 45
The Dalles 42
Boardman 40
Des Moines 37
Buffalo 33
São Paulo 31
New York 30
Munich 28
Jinan 26
Ho Chi Minh City 22
Lancaster 21
San Mateo 21
Tianjin 20
Haikou 12
Phoenix 12
Turku 12
Warsaw 12
Woodbridge 12
Belo Horizonte 11
Montreal 11
Rio de Janeiro 11
Tashkent 11
Ardabil 10
Brasília 10
Shenyang 10
Wilmington 10
Nanchang 9
Santa Clara 9
Brussels 8
Guangzhou 8
Nanjing 8
Stockholm 8
Chennai 7
Denver 7
Johannesburg 7
Seattle 7
Bremen 6
Changsha 6
Contagem 6
Guarulhos 6
Hebei 6
Houston 6
Redondo Beach 6
Turin 6
Amman 5
Baghdad 5
Boston 5
Brno 5
Curitiba 5
Dhaka 5
Fuzhou 5
Goiânia 5
Hangzhou 5
Milan 5
Monmouth Junction 5
Ningbo 5
Pune 5
San Francisco 5
Sorocaba 5
Taiyuan 5
Taizhou 5
Washington 5
Zhengzhou 5
Asunción 4
Atlanta 4
Augusta 4
Brooklyn 4
Campinas 4
Frankfurt am Main 4
Hanoi 4
Helsinki 4
Istanbul 4
London 4
Mumbai 4
Norwalk 4
Orem 4
Praia Grande 4
Santo André 4
Tokyo 4
Volta Redonda 4
Anápolis 3
Camaçari 3
Düsseldorf 3
Florianópolis 3
Hefei 3
Totale 4.028
Salva come PNG Salva come JPEG
Nome #
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 191
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 163
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 149
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 147
5-Ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi e potenziali agenti antiiperglicemizzanti 144
5-Arylidene-2,4-thiazolidinediones. Synthesis and in vitro activity as ALR2 inhibitors 140
4-Carbossiamido-9-fluorenoni: proprietà anti-HSV-2 e immunostimolanti 139
9-fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II 139
5-Ariliden-2,4-tiazolidindioni potenziali antidiabetici inibitori della protein tirosina fosfatasi 1B 138
FLUOROCONTAINING D-CYCLOSERINES - SYNTHESIS AND INVITRO EVALUATION OF ANTIMICROBIAL AND ANTIVIRAL ACTIVITIES 132
5-Arilmetilen- e 5-arilmetil-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 130
Design and synthesis of 5-arylidene-2-imino-4-thiazolidinones Celecoxib analogues as antiinflammatory and anticancer agents 129
2 '-[1-(4-Fluorophenyl)ethyl]isonicotino-kappa N-hydrazide- cyanoborane 127
Antimycobacterial in vitro activity of cobalt(II) isonicotinoylhydrazone complexes. Part 10 126
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 125
Bistiazolidinoni chirali: SARs molecular modeling, inibizione COX-I/COX-2 124
Biocatalysed synthesis of beta-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3: IFN-inducing and anti-HSV-2 properties 121
Configurational assignments of the diastereomers of 3,3 '-(1,2- ethanediyl)bis[2-(3-fluorophenyl)-5-methyl-4-thiazolidinone] derivative with four stereogenic centers 120
Chiral 3,3 '-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4- thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling 119
Facile biocatalytic access to 9-fluorenylmethyl polyglycosides: evaluation of antiviral activity on immunocompetent cells 116
5-Arylidene-2,4-thiazolidinediones as protein tyrosine phosphatases inhibitors 115
Nickel(II) 2,6-diacetylpyridine bis(isonicotinoylhydrazonate) and bis(benzoylhydrazonate) complexes: Structure and antimycobacterial evaluation. Part XI 115
Modeling and biological evaluation of 3.3 '-(1,2- ethanediyl)bis[2-(4-methoxyphenyl)-thiazolidin-4-one], a new synthetic cyclooxygenase-2 inhibitor 110
Design and synthesis of DNA-intercalating 9-fluoren-beta-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agents 109
Cyanoborane adducts of isonicotinohydrazides. Synthesis and evaluation of antineoplastic activity. 107
In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones 102
Synthesis and antiinflammatory, analgesic activity of 3,3’-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds. Part 10. 102
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 100
Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones 98
Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors 96
Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9 95
Relazioni Struttura/Attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 94
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I 94
INH-related hydrazides and cyanoboranes with antimycobacterial in vitro activity 91
In vitro antimycobacterial activities of 2 '-monosubstituted isonicotinohydrazides and their cyanoborane adducts 90
Progettazione, sintesi e attivita' farmacologica di nuovi derivati fluorenonici intercalanti 89
Evaluation of COX-2 selectivity and molecular modeling of novel 3,3'-(1,2-ethanediyl)bis-[2-(methoxyphenyl)-thiazolidin-4-ones] with antiinflammatory activity 88
Inibitori COX-2 selettivi a struttura tiazolidinonica. Valutazione dell'attività citotossica su linee cellulari di carcinoma del colon umano 87
Fluoren b-O-glucosides: biosynthesis and DNA-intercalating activity evaluation 87
Tilorone analogues with IFN-inducing and anti-HSV-2 activity 87
Progettazione e sintesi di derivati fluorenici intercalanti ad attività IFN-inducente ed anti-HSV-2 87
Nuclear magnetic resonance of psychotherapeutic agents. IV. Conformational analysis of 2,3-dihydro.1H-1,4-benzodiazepines 86
In vitro Antimycobacterial Activity of Isoniazid-related Metalchelates 84
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 84
Halogenated isoniazid derivatives .6. Evaluation of anti-HSV-1 and anti-HIV-1 in vitro activities of fluorinated analogues 83
In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: Part 14 82
Risonanza magnetica nucleare di 1,4-benzodiazepine. Accoppiamento attraverso lo spazio di 2,3-diidro-1H-1,4-benzodiazepine 1-sostituite 82
Synthesis and in vivo/ex vivo antiinflammatory evaluation of 5-arylidene-2-imino-4-thiazolidinones as potential celecoxib analogues 81
Lipophilic analogs of isoniazid with antiproliferative in vitro activity - VIII 80
Nuclear magnetic resonance of 1,4-benzodiazepines. II. Stereochemistry of 1,3-dihydro-2H-1,4-benzodiazepin-2-ones by lanthanide shift reagents 80
Tetraplex DNA specific ligand based on the fluorenone-carboxamide scaffold. 79
Nuclear magnetic resonance spectra of psychotherapeutic agents. V. Conformational analysis of 1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-ones 78
Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI. 77
Isonicotinoilidrazoni fluorurati: reattività ed attività antimicobatterica ed anti-HIV 75
Isonicotinoilidrazoni: reattività con diazometano ed attività antimicobatterica ed anti-HIV 74
Sintesi, attività in vitro e SARs di 2,4-tiazolidindioni inibitori dell'aldoso reduttasi 73
In Vitro Aldose Reductase Inhibitory Activity of 5-Benzyl-2,4-thiazolidinediones 71
Metal(II) complexes with isoniazid analogues: synthesis and pharmacological activity 67
Nuclear magnetic resonance spectra of psychotherapeutic agents. III. Stereochemistry of 1-methyl5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-2,4-diones 65
Reattività di isonicotinoilidrazoni con diazometano 62
Metalchelati di aroilidrazoni. Sintesi e valutazione dell'attività antitubercolare 59
Totale 6.284
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 0 0 0 0 50 5 49 1 53 67 11
2021/2022413 6 94 3 10 22 0 27 14 6 27 70 134
2022/20231.161 94 130 57 100 76 118 27 57 476 9 17 0
2023/2024204 16 34 32 13 24 42 1 13 0 3 0 26
2024/20251.093 13 9 19 79 42 33 42 212 297 65 107 175
2025/20262.033 180 318 296 241 241 757 0 0 0 0 0 0
Totale 6.284